DE:HXB Stock Latest News
The FlyAIM ImmunoTech CEO issues letter to stockholders1M agoAIM
Company AnnouncementsAIM ImmunoTech Executes Debt-Reducing Equity Exchange Agreements1M ago8KAIM
Company AnnouncementsAIM ImmunoTech Reduces Debt via Equity Exchange Agreements1M ago8KAIM
Company AnnouncementsAIM ImmunoTech Extinguishes Debt Through Equity Exchanges1M ago8KAIM
The FlyAIM ImmunoTech granted patent for Ampligen2M agoAIM
Company AnnouncementsAIM ImmunoTech CEO Urges Biodefense Military Integration2M ago8KAIMCompany AnnouncementsAim Immunotech’s Aggressive Equity Issuance Raises $10.4M but Poses Major Dilution Risk for Shareholders2M agoAIM
Company AnnouncementsAIM ImmunoTech Ends At-The-Market Equity Program2M ago8KAIM
Company AnnouncementsAIM ImmunoTech Stockholders Approve Key Equity Proposals3M ago8KAIM
Company AnnouncementsAIM ImmunoTech Regains NYSE American Listing Compliance4M ago8KAIM
Company AnnouncementsAIM ImmunoTech Raises Capital via Registered Direct Offering4M ago8KAIM
Company AnnouncementsAIM ImmunoTech Updates Bylaws on Shareholder Voting Standards4M ago8KAIM
The FlyAIM ImmunoTech Inc trading halted, news pending4M agoAIM- Company AnnouncementsAIM ImmunoTech Highlights Ampligen’s Emerging Ebola Treatment Potential5M ago8KAIM
Company AnnouncementsAIM ImmunoTech Announces Equity Offering to Bolster Capital5M ago8KAIM
